Ephedrine/caffeine safety, effectiveness study under way at Harvard and Vanderbilt.
This article was originally published in The Tan Sheet
Executive Summary
EPHEDRINE/CAFFEINE STUDY UNDER WAY AT HARVARD AND VANDERBILT, funded by the Washington, D.C.-based Ad Hoc Committee on the Safety of Ma Huang and organized by the San Diego, Calif.-based consulting firm Science, Toxicology & Technology. The multi-center clinical trial is in the initial stages of subject recruitment. The study will "generate competent and reliable scientific evidence about the safety and effectiveness of ephedrine and caffeine-containing dietary supplements at ephedrine levels less than those being considered by the FDA," ST&T said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning